Category Archives: healthcare

Japan’s Non-Hodgkin Lymphoma Market to Top $1 Billion by 2020

The Non-Hodgkin Lymphoma (NHL) treatment market in the Asia-Pacific (APAC) countries of India, Australia, China and Japan will expand from $1.1 billion in 2013 to $1.7 billion by 2020, with Japan remaining the largest contributor to growth, according to GBI Research. The company’s new report says that Japan had a 67.2% share of the APAC […]
Also posted in Global | Tagged , , , , , , | Leave a comment

What's the Future of European Health Policy?

What can be gleaned about the direction that health policy will take for the next five years under the new European Commission, scheduled to take office at the beginning of November? Peter O’ Donnell address this question in his new Applied Clinical Trials column here.
Also posted in Europe, Global, Guest Blog, Op-Ed, Regulatory | Tagged , , | Leave a comment

GSK Joins UK–South African Effort to Target Non-communicable Diseases

By Casey McDonald. GSK will weigh in on non-communicable diseases (NCDs) in Africa with a £1m contribution and a commitment of internal R&D expertise supporting researchers from South African institutions, the company announced this month.
Also posted in Emerging Markets, Global | Tagged , , , , | Leave a comment

Ebola Crisis Could Spur Broader R&D Efforts

Up until a few months ago, there was little industry interest or public support for developing vaccines and treatments to combat the Ebola virus. Now the rush is on to launch clinical trials of therapies with some potential effectiveness against the disease. The situation has also encouraged FDA and regulatory authorities to facilitate these efforts […]
Also posted in R&D, Regulatory | Tagged , , , | Leave a comment

Healthcare Reform in China: A Doubled-Edge Sword for Foreign Firms?

The Chinese market is attractive to foreign investors for many reasons. It is the world’s third largest market for pharmaceuticals with annual sale of US$71 billion.  In fact, it is poised to become the second largest market in 2015 given that its annual growth rate of sales is between 15 and 20%, according to Yanzhong […]
Also posted in Biotech, Emerging Markets, Global, Guest Blog, Regulatory | Tagged , | Leave a comment
  • Categories

  • Meta